Tilray Brands Joins European Talks on Cannabis Regulations
Tilray Brands Inc (TLRY) is participating in European discussions concerning cannabis regulations.
26 stories found
Tilray Brands Inc (TLRY) is participating in European discussions concerning cannabis regulations.
Tilray Brands (TLRY) is reportedly experiencing continued strength driven by its international business operations.
Tilray Brands, Inc. released its Q3 2026 earnings summary, detailing the company's financial performance for the period.
Tilray Brands announced a significant expansion of its medical cannabis product portfolio in Australia, strengthening its presence in the market.

Tilray Brands has agreed to acquire key assets of BrewDog across North America, expanding its portfolio and presence in the American market, following a previous UK rescue deal.
Tilray Brands has expanded its global footprint by completing the acquisition of BrewDog Brewing Australia's assets, further solidifying its presence in the Australian market.
Tilray Brands, Inc. (TLRY) is strengthening its U.S. market presence through a new long-term partnership with Carlsberg.
An analysis compares Canopy Growth and Tilray Brands to determine which stock has greater potential to generate significant wealth for investors.
Tilray Brands and Carlsberg Group have established an exclusive multi-year brewing partnership in the United States.
Despite speculation, Tilray Brands is not expected to expand into the U.S. marijuana market anytime soon, according to a recent analysis.
Investors in Tilray Brands should not anticipate the company to post a profit anytime soon, according to recent analysis.
Tilray Brands announced its third-quarter financial results, showing double-digit year-over-year increases in most segmental revenues, though its alcohol segment experienced a 24% slump.
An investor expresses a strong negative sentiment towards Tilray Brands stock, advising against investment.

Lord's cricket ground has terminated its partnership with BrewDog following the acquisition of the beer company by Tilray Brands, which produces medicinal marijuana.

Tilray Brands, which produces medicinal cannabis and craft beer in the US, bought the BrewDog brand in a £33 million deal.
Craft brewer Tilray Brands has announced a new licensing agreement with Carlsberg Group to brew, market, and distribute Carlsberg and other associated brands in the United States.
Alliance Global has maintained a neutral rating on Canopy Growth Corporation (CGC), while Canaccord has expressed a bullish outlook on Aurora Cannabis Inc. (ACB).
An article delves into the factors behind Tilray Brands' disappointing investment returns, despite its operations within the legal marijuana market.
Jefferies analysts maintain a bullish outlook on Tilray Brands, citing the company's strong cannabis sales and an upbeat future outlook.
The CEO of Tilray Brands has commented on the future of BrewDog, emphasizing the need for stability within the company.
An analysis questions whether Tilray Brands' diversification strategy will ultimately benefit investors, examining the potential outcomes of its business decisions.
Tilray Brands has announced expectations to generate $1.2 billion in revenue in the upcoming year, with the company's strategy potentially surprising investors.
Tilray Brands (TLRY) is showing strong performance, driven by its diversification into beverages and the launch of new spring products.
Tilray Brands is reportedly close to finalizing a deal to acquire assets from BrewDog, a craft beer company.
Tilray Brands has announced a partnership with Carlsberg to handle brewing operations in the United States.